Skip to content


Our aim is to find disease modifying therapies for the diseases that cause dementia – please find our latest contributions below.

We’re looking for targets that have been unexplored by the pharmaceutical industry, broadening our focus to novel proteins and pathways implicated in neurodegenerative diseases and will draw on academic expertise to find these.

London Labs